What is the biological variation of free T4 (Thyroxine) and Thyroid-Stimulating Hormone (TSH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Biological Variation of Free T4 and TSH

The within-subject biological variation (CVI) for TSH is approximately 20-34%, while free T4 demonstrates much tighter within-subject variation at approximately 3.6-5.1%, making free T4 a more stable marker for monitoring individual thyroid function over time.

Within-Subject Biological Variation (CVI)

TSH Biological Variation

  • TSH demonstrates substantial within-subject biological variation of approximately 19.7-34.54% in healthy individuals 1, 2
  • The within-subject variation of TSH is approximately 20% in healthy people and can reach up to 30% in patients on hemodialysis 3
  • A more recent study using the Cobas 602 analyzer found CVI of 19.7% for TSH in European volunteers 1
  • Turkish population data showed CVI of 22.3% (95% CI: 19.3-26.3%) for TSH 4
  • The 24-hour biological variation study reported CVI of 34.54% for TSH, with males showing lower variation than females 2

Free T4 Biological Variation

  • Free T4 shows much tighter within-subject variation, with CVI ranging from 3.57% to 5.1% across multiple studies 1, 2, 4
  • European data demonstrated CVI of 4.6% for free T4 1
  • The 24-hour variation study found CVI of 3.57% for free T4 2
  • Turkish population showed CVI of 5.1% (95% CI: 4.3-6.1%) for free T4 4
  • Long-term studies in patients with benign thyroid disease showed free T4 variation of less than 10% over years 5

Between-Subject Biological Variation (CVG)

TSH Between-Subject Variation

  • TSH demonstrates high between-subject variation (CVG) of 26.6-37.6%, reflecting the wide population-based reference ranges 1, 4
  • European volunteers showed CVG of 37.6% for TSH 1
  • Turkish population data revealed CVG of 26.6% (95% CI: 19.2-39.8%) for TSH 4

Free T4 Between-Subject Variation

  • Free T4 shows moderate between-subject variation with CVG of 8.0-10.8% 1, 2, 4
  • European data demonstrated CVG of 10.8% for free T4 1
  • The 24-hour study found CVG of 8.03% for free T4 2
  • Turkish population showed CVG of 8.2% (95% CI: 6.1-12.1%) for free T4 4

Clinical Implications: Reference Change Values (RCV)

TSH Reference Change Value

  • The difference in TSH concentration must exceed 54.7% in healthy people to represent a true biological change rather than normal variation 1
  • For patients on hemodialysis, TSH must change by 72% to be considered significant 3
  • Turkish data showed RCV of -40.3% (decrease) to +67.6% (increase) for TSH 4

Free T4 Reference Change Value

  • Free T4 requires only a 12.7-16.2% change to represent true biological significance 1, 4
  • European data showed RCV of 16.2% for free T4 1
  • Turkish population demonstrated RCV of -12.7% (decrease) to +14.5% (increase) for free T4 4

Index of Individuality (II)

Clinical Interpretation

  • TSH has an index of individuality of 0.2-0.84, indicating moderate to high individuality 1, 4
  • Free T4 demonstrates II of 0.2-0.61, suggesting high individuality and supporting the use of individual monitoring rather than population-based reference ranges 1, 2, 4
  • All thyroid parameters except TSH show II ≤ 0.63, indicating that population-based reference ranges have limited utility for individual patient monitoring 2

Sex Differences in Biological Variation

  • Males demonstrate lower within-subject variation and lower index of individuality for all thyroid hormones compared to females 2
  • Concentrations of TSH, T3, T4, free T3, and free T4 are significantly different between sexes, warranting sex-stratified interpretation 2

Long-Term Stability

  • Patients on stable levothyroxine therapy show the lowest coefficient of variation (<10%) for T3 and T4 over periods of 3-13 years 5
  • Even in patients without medication, T3 and T4 demonstrate variation of only approximately 10% over years 5
  • TSH shows wider long-term variation, particularly after radioiodine therapy (>30%), compared to T3 and T4 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.